BRKR Relative Valuation
BRKR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BRKR is overvalued; if below, it's undervalued.
Historical Valuation
Bruker Corp (BRKR) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.72 is considered Undervalued compared with the five-year average of 27.56. The fair price of Bruker Corp (BRKR) is between 58.41 to 82.83 according to relative valuation methord. Compared to the current price of 42.45 USD , Bruker Corp is Undervalued By 27.33%.
Relative Value
Fair Zone
58.41-82.83
Current Price：42.45
27.33%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.44
P/B
Median3y
7.35
Median5y
8.31
2.71
FCF Yield
Median3y
1.80
Median5y
1.99
Competitors Valuation Multiple
The average P/S ratio for BRKR's competitors is 4.66, providing a benchmark for relative valuation. Bruker Corp Corp (BRKR) exhibits a P/S ratio of 1.81, which is -61.07% above the industry average. Given its robust revenue growth of 11.04%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Bruker Corp (BRKR) currently overvalued or undervalued?
What is Bruker Corp (BRKR) fair value?
How does BRKR's valuation metrics compare to the industry average?
What is the current P/B ratio for Bruker Corp (BRKR) as of Jul 08 2025?
What is the current FCF Yield for Bruker Corp (BRKR) as of Jul 08 2025?
What is the current Forward P/E ratio for Bruker Corp (BRKR) as of Jul 08 2025?